Strategic Stake in Digital Health Company
Switzerland
About this business
This digital health company opportunity offers moderate industry attractiveness, with limited financial and operational data available. The asking stake size and location are neutral factors, while there are no clear urgency signals for the transaction. Score: 64/100 — Industry: 20/25, Pricing: 15/25, Geography: 10/20, Urgency: 10/15, Quality: 9/15 --- Cette opportunité dans la santé numérique présente une attractivité sectorielle modérée, avec des données financières et opérationnelles limitées. La taille de participation demandée et l'emplacement sont des facteurs neutres, tandis qu'il n'y a pas de signaux clairs d'urgence pour la transaction.
Full description available after signup.
Business Profile
AI-compiledA Swiss digital health company (AG) is offering a strategic minority stake of up to 25.1% to a qualified investor. Based in Region 8 (Zürich area), the company operates in the growing digital health sector with disclosed annual revenue between €510,000–€1.0 million, positioning it as an established SME in Switzerland's thriving healthcare technology landscape.
Overview
This digital health company, structured as an Aktiengesellschaft (AG), operates in Switzerland's healthcare technology sector with a presence in Region 8 (Zürich area). The business has achieved commercial traction with revenue in the €510,000–€1.0 million range, indicating an operational business beyond the startup phase. As a digital health enterprise, the company likely provides technology-enabled healthcare solutions, software, or services addressing the digitalization needs of Switzerland's healthcare market.
Products & Services
- ·Digital health technology solutions or platforms
- ·Healthcare software or services (specific offerings not disclosed)
- ·Technology-enabled healthcare delivery or management tools
Market position
The company operates in Switzerland's expanding digital health market, benefiting from strong regulatory frameworks, high healthcare spending per capita, and increasing digitalization of medical services. With revenue approaching €1 million, it has achieved meaningful commercial validation in a competitive but growing sector.
Financial summary
Revenue: €510,000–€1,000,000 (disclosed range). Operating result (EBITDA): Available upon request (not publicly disclosed). Asking price or valuation: Not disclosed; will depend on negotiation for the minority stake of up to 25.1%. Margins and profitability metrics are not provided and should be verified during due diligence. All financial figures beyond the stated revenue range are estimates pending disclosure.
Investment highlights
- +Strategic minority position (up to 25.1%) allows participation without operational control obligations
- +Exposure to high-growth digital health sector in Switzerland, a leading healthcare market
- +Established revenue base (€0.5–1.0M) demonstrates commercial viability and market acceptance
- +Zürich region location provides access to talent, capital, and healthcare innovation ecosystem
- +AG structure offers clear governance and investor protection under Swiss corporate law
Growth opportunities
- →Expansion of digital health solutions to additional Swiss cantons or DACH region markets
- →Development of new product features or service lines leveraging existing platform and customer relationships
- →Strategic partnerships with hospitals, insurers, or pharmaceutical companies to scale distribution
- →Potential for follow-on investment or majority acquisition as company matures
Considerations
- ·Limited financial disclosure (operating result on request only) requires thorough due diligence on profitability, cash flow, and capital requirements
- ·Minority stake structure (max 25.1%) means limited governance rights and dependence on majority shareholders' strategy
- ·Specific digital health product, customer base, competitive differentiation, and regulatory approvals are not disclosed
- ·Digital health sector faces regulatory complexity (data protection, medical device regulations) and reimbursement challenges that may impact scalability
Ideal buyer
This opportunity suits a strategic investor (healthcare provider, insurer, pharma/medtech company) seeking digital health exposure, a family office or individual investor with healthcare sector knowledge interested in minority stakes, or a private equity fund building a digital health portfolio in the DACH region.
Compiled by Alpine Business from the listing, the Swiss commercial register, and public sources. Verify all figures during due diligence.
What you'll see after signing the NDA
- → Exact revenue, EBITDA, and asking price
- → Full business description and operational details
- → Seller contact information
- → Customer concentration and key revenue sources
- → Reason for sale and ideal buyer profile
- → Direct introduction to the seller
Confidential. Legally binding under Swiss law. Free.
Similar businesses for sale
Profitable Swiss Wholesale Company in the Field of High-Quality Medical Technology Aids
Switzerland
CHF 250K – 500K
Medical Practice
Lucerne
CHF 500K – 1M
A TOP Occupational Therapy Practice for Sale
Zürich
Not disclosed
An Established Cosmetics and Foot Care Studio Seeking a Successor
Switzerland
Not disclosed